Key Takeaways
- • Hedge funds lost 2.83 per cent in January 2016 according to the Barclay Hedge Fund Index compiled by BarclayHedge, the worst start to a year in eight years, since the index fell 3.26 per cent in January 2008.
- • 15 of Barclay's 18 hedge fund indices posted losses in January, with the Healthcare and Biotechnology Index hardest hit at a 7.10 per cent decline.
- • Founder and president Sol Waksman attributed the weakness to slowing fourth-quarter US growth, concerns about the Chinese economy and a sharp fall in energy prices.
- • The Barclay Fund of Funds Index declined 2.59 per cent in January, while the Equity Short Bias Index rose 3.21 per cent, the strongest gain among strategies tracked.
Summary
Sol Waksman, founder and president of BarclayHedge, said slowing fourth-quarter growth in the United States, heightened concerns about the Chinese economy and a precipitous decline in energy prices all weighed heavily on investor sentiment. Losses were broad: 15 of Barclay's 18 hedge fund indices recorded negative returns in the month.
The Healthcare and Biotechnology Index was the worst performer, falling 7.10 per cent. Waksman noted that despite reported earnings growth in the healthcare sector, the NASDAQ Biotech Index fell 21 per cent. Other notable declines included the Emerging Markets Index (down 4.87 per cent), Equity Long Bias (down 4.84 per cent), Technology (down 3.82 per cent), European Equities (down 3.48 per cent), Distressed Securities (down 2.83 per cent) and the Event Driven Index (down 2.67 per cent).
A small number of strategies posted gains. The Equity Short Bias Index rose 3.21 per cent, Merger Arbitrage added 0.51 per cent and Equity Market Neutral gained 0.18 per cent. The Barclay Fund of Funds Index fell 2.59 per cent over the month.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.